Президента Российского общества сомнологов,
заслуженного врача РФ, профессора, д.м.н.

Список литературы


Список литературы

1.     Willis, T. De anima brutorum quæ hominis vitalis ac sensitiva est, excertitationes duæ; prior physiologica ejusdem naturam, partes, potentias et affectiones tradit; altera pathologica morbos qui ipsam, et sedem ejus primarium, nempe ceerebrum et nervosum genus atti/ trans. by R. Davis. London, 1683: Two Discourses concerning The Soul of Brutes, Which is that of the Vital and Sensitive of Man Samuel Pordage. London, 1672.

2.     Ekbom, K. A. Restless legs. Acta Med Scand, 1945, 158 — pp.5–123.

3.     Teive, Hélio A.G.; Munhoz, RP; Barbosa, ER. Professor Karl-Axel Ekbom and restless legs syndrome. Parkinsonism & Related Disorders, 2009, 15(4)- pp.254–7.

4.     Ulfberg, J. The legacy of Karl-Axel Ekbom. Sleep Medicine, 2004, 5(3) — pp.223–4.

5.     Allen, R. Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Medicine A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health, 2003, 4 (2) — pp.101–19.

6.     Restless legs syndrome. Causes, Diagnosis and Treatment [Electronic resource]/ RLS Foundation, 2011. URL: http://www.rls.org/Document.Doc?&id=428. [Cited: 08.27.2011].

7.     RLS Information. European Restless Legs Syndrome Study Group. [Electronic resource]/ RLS Foundation, 2011. URL:http://www.eurlssg.org/index.php?option=com_content&view=article&id=1&Itemid=3. [Cited: 08.27. 2011].

8.     Phillips, B; Young, Y; Finn, L; Asher, K; Hening, WA; Purvis, C. Epidemiology of restless legs symptoms in adults. Arch Intern Med, 2000, 160(14) — pp. 2137-2141.

9.     Nichols, Deborah A. ; Allen, Richard P.,; Grauke, John H; Brown, John B.; Rice, Matthew L.; Hyde, Pamela R.; Dement, William C.; Kushida, Clete A. Restless Legs Syndrome Symptoms in Primary Care. A prevelens Study. Arch Intern Med, 2003, 163- pp.2323-2329.

10. Högl, B. et al. Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology, 2005, 64(11) — pp. 1920-1940.

11. Tison, F.;Crochard, A.; Leger, D.; Bouee, S.; Lainey, E.; Hasnaoui, A. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology, 2005, 65(2) — pp. 239-246.

12. Björvatn, B.; Leissner, L; Ulfberg, J; et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries . Sleep Med , 2005, 6(4) — pp. 307-312.

13. O’Keeffe, ST; Egan, D; Myers, A; Redmond, S. The frequency and impact of restless legs syndrome in primary care. Ir Med J, 2007, 100 — pp. 539-42.

14. Innes, Kim E.; Self, Terry Kit ; Agarwal, Parul. Prevalence of restless legs syndrome in North American and Western European populations: A systematic review. Sleep Medicine, 2011, 12(7)- pp.623-634.

15. Allen, RP; Stillman, P; Myers, AJ. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics. Sleep Med , 2010, 11(1) — pp.31-37.

16. Sevim, S; Dogu, O; Camdeviren, H; Bugdayci, R; Sasmaz, T; Kaleagasi, H; et al. Unexpected low precalence and unusual characteristics of RLS in Mersin, Turkey. Neurology, 2003, 61(11) — pp. 1562-1569.

17. Hadjigeorgiou, GM; Stefanidis, I; Dardiotis, E; Aggellakis, K; Sakkas, GK; Xiromerisiou, G; et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol, 2007, 14(11) — pp. 1275-1280.

18. Kim, J; Choi, C; Shin, K; et al. Prevalence of restless legs syndrome and associated factors in the Korean adult population: the Korean Health and Genome Study. Psychiatry Clin Neurosci , 2005, 59- pp.350–53.

19. Kageyama, T; Kabuto, M; Nitta, H; et al. Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults. Psychiatry Clin Neurosci, 2000, 54 — pp. 296-8.

20. Tan, EK; Seah, A; See, SJ; Lim, E; Wong, MC; Koh, KK. Restless legs syndrome in an Asian population: A study in Singapore. Mov Disord, 2001, 16 — pp. 577-9.

21. Allen, RP. Race, iron status and restless legs syndrome. Sleep Med , 2002, 3- pp. 467-8.

22. Berger, K.; Luedemann, J; Trenkwalder, C; John, U; Kessler, C. Sex and the risk of restless legs syndrome in the general population. Archives of Internal Medicine, 2004, 164 (2) — pp. 196-202.

23. Lee, HB; Hening, WA; Allen. RP; et al. Race and restless legs syndrome symptoms in an adult community sample in east Baltimore. Sleep Med , 2006, 7 – pp. 642–5.

24. Johnson, E. Omnibus sleep in America poll. National Sleep Foundation. Washington, DC. 1998, 8-9 — pp. 41-3.

25. Winkelman, JW; Chertow, GM; Lazarus, JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis, 1996, 28 — pp.372–8.

26. Manconi, M; Govoni. V; De Vito, A; et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med, 2004, 5- pp. 305–8.

27. Purvis, C; Phillips, B; Asher, K.;et al. Self reports of restless legs syndrome; 1996 Kentucky behavior risk factor surveillance survey. Sleep Res, 1997, 26 — p. 474.

28. Ulfberg, J; Björvatn, B; Leissner, L; Gyring, J; Karlsborg, M; Regeur, L; et al. Comorbidity in restless legs syndrome among a sample of Swedish adults. Sleep Med, 2007, 8(7-8) — pp. 768-772.

29. Lavigne, G; Montplaisir, J. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep, 1994, 17 — pp. 739–43.

30. Earley, CJ. Restless legs syndrome. N Engl J Med, 2003, 348- pp. 2103–2109.

31. Picchietti, D; Allen, RP; Walters, AS; Davidson, JE; Myers, A; Ferini-Strambi, L. Restless legs syndrome: prevalence andimpact in children and adolescents – the Peds REST study. Pediatrics, 2007, 120- pp.253–66.

32. Allen, PR; Walters, AS; Montplaisir, J; Hening, W; Myers, A; Bell, TJ; Ferini-Stramb,  L. Restless Legs Syndrome Prevalence and Impact: REST. Arch Intern Med, 2005, 165- pp.1286-1292.

33. RLS Information . European Restless Legs Syndrome Study Group. [Electronic resource]/ RLS Foundation, 2011. URL:http://www.eurlssg.org/index.php?option=com_content&view=article&id=1&Itemid=3. [Cited: 28.08.2011].

34. Миронов С.П., Щепин О.П., Романов А.И., Максимова Т.М.. Концептуальная и экспериментальная проработка эпидемиологии нарушений сна у населения России.// Кремлевская медицина. Клинический вестник. – 1998. – 5. – с. 17–23.

35. Sun, ER; Chen, CA; Ho G; Earley, CJ; Allen, RP. Iron and the restless legs syndrome. Sleep, 1998, 21(4) — pp.371–377.

36. Bayard, M; Avonda, T; Wadzinski, J . Restless Legs Syndrome. Am Fam Physician, 2008, 78(2) — pp.235-240.

37. Pittock, SJ; Parrett, T; Adler, CH; Parisi, JE; Dickson, DW; Ahlskog, JE. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord , 2004, 19- pp.695–9.

38. Desai, AV; Cherkas, LF; Spector, TD; Williams, AJ . Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: A twin study. Twin Res, 2004, 7- pp.589–95.

39. Chen, S; Ondo, WG; Rao S; Li L; Chen Q;Wang Q . Genome wide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet, 2004, 74- pp.876–85.

40. Winkelmann, J; Muller-Myhsok, B; Wittchen, HU; et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol, 2002, 52- pp.297–302.

41. Bonati, MT; Ferini-Strambi, L; Aridon, P; Oldani, A; Zucconi, M; Casari, G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain,  2003, 126- pp.1485–92.

42. Desautels, A; Turecki, G; Montplaisir,J; Sequeira, A; Verner, A; Rouleau, GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet, 2001, 69- pp.1266–70.

43. Liebetanz, KM; Winkelmann, J; Trenkwalder, C; et al. RLS3: fine-mapping of an autosomal dominant locus in a family with intra-familial heterogeneity. . Neurology, 2006, 67- pp.320–1.

44. Muhle, H; Neumann, A; Lohmann-Hedrich, K; et al. . Clinical and genetic features of 22 families. . Mov Disord , 2008, 23 — pp.1113–21.

45. Killick, К; Yee, B. Restless legs syndrome. Australian Family Physician, 38(5)- pp. 296-300.

46. Connor, JR; Boyer, PJ; Menzies, SL; et al. . Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology, 2003, 61- pp.304–9.

47. Allen, RP; Barker, PB; Wehrl, F; Song, HK; Earley, CJ . MRI measurement of brain iron in patients with restless legs syndrome. Neurology, 2001, 56- pp.263–5.

48. Winkelmann, J; Stautner, A; Samtleben, W; Trenkwalder, C.. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation . Mov Disord , 2002, 17- pp.1072–6.

49. Ohayon, MM; Roth, T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res, 2002, 53(1) — pp.547-54.

50. Hornyak, M; Trenkwalder, C. Restless legs syndrome and periodic limb movement disorder in the elderly. J Psychosom Res, 2004, 56(5) — pp.543-8.

51.     Montplaisir, J; Boucher, S; Poirier, G; Lavigne, G; Lapierre, O; Lesperance, P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord, 1997, 12 — pp.61-65.

52.     Yilmaz, Kutluhan; Kilincaslan, Ayse; Aydin, Neriman; Kor, D. Deniz. Prevalence and correlates of restless legs syndrome in adolescents. Developmental Medicine & Child Neurology, 2011, 53- pp.40–47

53. Garcia-Borreguero, Diego D; Stillman, P; Benes, H; Buschmann, H; Chaudhuri, KR; Rodríguez, VM Gonzalez; Högl, B; Kohnen, R; Monti, G Carlo; Stiasny-Kolster, K; Trenkwalder, С; Williams, AM. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurology,  2011, 11- p.28.

54. Management of restless legs syndrome in primary care. [Electronic resource]/ Guidelines.co.uk, 2011. URL: http://www.eguidelines.co.uk/eguidelinesmain/guidelines/summaries/central_nervous_system/rlsuk_restless_legs.php. [Cited: 31.08.2011].

55. American Sleep Disorders Association. The international classification of sleep disorders, revised: diagnostic and coding manual. Rochester, Minn.: American Sleep Disorders Association, 1997.

56. American Academy of Sleep Medicine. Restless legs syndrome. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine. Westchester, IL : s.n., 2005- pp. 178–181.

57. Walters, AS; LeBrocq, C; Dhar, A; et al. International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Medicine, 2003, 4- pp. 121–132.

58. Tan, EK; HO, SC; Eng, P; Loh, LM; Lum, SY; Teoh, ML; Yih, Y; Khoo, D. Restless legs symptoms in thyroid disorders. Parcinsonism Relat Disord, 2004, 10(3) — pp.149-51.

59. Ondo, W; Jankovic, J. Restless legs syndrome: clinicoethiologic correlates. Neurology , 1996, 47(6) — pp.1435-1441.

60. Housman, D; Gephardy, S; Earley, C; Allen, R. Critical age for development of daily restless leg syndrome symptoms . Sleep, 2001, 24- p.A355.

61. Allen, RP; Earley, CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. . Sleep Med, 2000, 1(1) — pp.11-19.

62. Nofzinger, EA; Fasiczka, A; Berman, S; Thase, ME. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry, 2000, 61(11) — pp.858-62.

63. Inoue, Y; Kuroda, K; Hirata, K; Uchimura, N; Kagimura, T; Shimizu, T. Long-term open-label study of pramipexole in patients with primary restless legs syndrome. J Neurol Sci, 2010, 294(1-2) — pp.938-43.

64. Inoue, Y; Hirata, K; Kuroda, K; Fujita, M; Shi. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study. Sleep Med,  2010, 11(1) — pp. 497-500.

65. Garcia-Borreguero, D; Allen, RP; Benes, H, Earley, C; Happe, S; Hogl, B; Kohnen, R; Paulus, W; Rye, D; Winkelmann, J. Augmentation as a treatment complication of restless legs syndrome: Concept and management. Mov Disord, 2007, 22(18) — pp.476-484.

66. Högl, B; Garcia-Borreguero, D; Trenkwalder, C; Ferini-Strambi, L; Hening, W; Poewe, W; Brenner, SS; Fraessdorf, M; Busse, M; Albrecht, S; Allen, RP. Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep medicine, 2011, 12(4) — pp.351-60.

67. Garcia-Borreguero, D; Larrosa, O; Williams, AM; Albares, J; Pascual, M; Palacios, JC; Fernandez, C. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology, 2010, 74(23) — p.1897.

68. Vignatellia, L; Billiardb, M; Clarenbachc, P; Garcia-Borreguero, D; Kaynake, D; Liesienef, V. EFNS guidelines on management of restless legs syndrome and periodic. European Journal of Neurology, 2006, 13- pp.1049–1065.

Перейти к Оглавлению